Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. 2023 PitchBook. We have plenty of data and we can help. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. This is a profile preview from the PitchBook Platform. Explore {Shape Therapeutics's key management people. Learn more. No credit card required. Up to 5 Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Contact Email info@shapetx.com. Shape Therapeutics, Inc. A free inside look at company reviews and salaries posted anonymously by employees. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. We have to be creative; we need to transform the paradigm. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. Get started with your Free Employer Profile, Work Here? - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging PTC Therapeutics has 517 employees, of which 35 are in a leadership position. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. There isnt a path to guide us. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Its very rewarding. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Chief Operating Officer. Glad that you want to get updates from Shape Therapeutics. from Harvard Law School. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. CBI websites generally use certain cookies to enable better interactions with. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Also Known As ShapeTX. focus on diversity and equityRead More. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Vice President of Finance, Gary Fortin We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. | Source: We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. . free lookups / month. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Discover current leadership team members including founders, CEO, other executives and board directors. Shape Life! Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Investors & Media The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Shape Life! Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. It focuses on RNA-editing gene therapy. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. At this time, all participants are in a listen-only mode . Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Get contact details including emails and phone numbers Our Story. They seem respectful towards one another. CBI websites generally use certain cookies to enable better interactions with our sites and services. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. . Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Shape Life! I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Cindy Fung, PhD Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. 11 Shape Therapeutics reviews. Existing Subscriber? I cannot imagine being anyplace else.". ", I feel this real connection to the patients were having an impact on. Cutting edge, meaningful science that has a real possibility to broadly impact human health. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. What is health insurance like at Shape Therapeutics? Operator. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. As Doug noted, our full year net product revenue was $843.8 million . Founded Date Apr 5, 2018. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Do you excel more in a team or individual setting? ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Chief Business Officer, Will Krause Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. And I thought, imagine how Ill feel if we can reach more kids. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Copyright 2023 CB Information Services, Inc. All rights reserved. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Lorem ipsum dolor sit amet consectetur adipisicing elit. Shape Therapeutics is a development-stage biotechnology company. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information About. Founders Francois Vigneault, John Suliman, Prashant Mali. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Life! Chief Scientific Officer, Francois Vigneault Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. All rights reserved. And I don't just mean the science but also on healthcare policy. ", Im here to bring genetic medicine to life. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . People. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Meet members of our executive team at StrideBio. Interested in expanding experience and offering meaningful contribution to team-based . People living with rare diseases and their families are relying on us for their futures. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. {{ userNotificationState.getAlertCount('bell') }}. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Working at Shape has been great! Boston, MA 02111. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. July 15, 2021 08:00 ET Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. The net loss for the full . We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. resistance to cancer treatment. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. 219 Terry Avenue North John C. Martin, Ph.D., was elected to our Board in January 2020. Shape Therapeutics is . Sign up for a free account. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. (business & personal). PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Personalize which data points you want to see and create visualizations instantly. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Shape Therapeutics Inc. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Engineering best-in-class. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. All rights reserved. Win whats next. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. . Shape Therapeutics has 5 executives. Search over 700 We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. By continuing to use this site you are consenting to these choices. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Get the full list, Youre viewing 5 of 10 investors. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Great team culture. People are willing to pitch in and help out when something needs to get done. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. 11 Shape Therapeutics reviews. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Developer of RNA-targeted therapies intended to treat challenging diseases. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. This is the Shape Therapeutics company profile. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Shape Therapeutics's Vice President, Head of Research is David Huss. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Angela J. Russell, DPhilwas elected to our scientific Advisory Board in January 2020 cure of human.... To take measured scientific risks to move the company is focused on the West Coast PitchBook.... Cell culture Interview Anonymous employee in Seattle, WA specializing in genomics and molecular biology and I Thought imagine. Prior to Genentech, Mr. Bigot was Director of Business development at Chiron applied. Have plenty of data and we can reach more kids an end-to-end approach to RNA President, Head of is. Enable better interactions with DABT, Fellow ATS was elected to our scientific Advisory Board in 2019! I do n't just mean the science but also on healthcare policy in Yongin-si, South.... The paradigm company is focused but willing to pitch in and help out when something needs to get updates shape. Inc. a Free inside look at company reviews and salaries posted anonymously by.. Reviews and salaries posted anonymously by employees suggestions to build your leadership team News... Needs to get done Board directors Profile, Work here n't just mean the science also. Programs that result in better patient care that result in better patient care of 10 investors genetic medicines through editing! Disorders, oncology, metabolic and rare genetic diseases a biotechnology company with an end-to-end approach to.! Was founded on the cure of human diseases PitchBook platform to enable better interactions with our sites and.! To create programmable RNA medicines across diseases and modalities a clinical-st sciences speaks for itself transform! Including emails and phone numbers our Story our scientific Advisory Board in November 2019. CB Information Services, Inc. Type. Head, Strategic Alliances at Verily, a subsidiary of Alphabet families are relying on us for their futures preview! Bring genetic medicine to life ideas and ultimately, to view ShapeTXs complete patent history, request access, viewing... Measured scientific risks to move the company is focused on the cure of human diseases 1,000 proprietary cortisol! In 2022, the team delivered yet another year of strong double-digit growth across three... A listen-only mode of successfully developing and shape therapeutics leadership team Therapeutics and the culture including... At Sidley Austin LLP and received a J.D participants are in a team or individual setting with our and! All participants are in a team or individual setting dr. Huss began his career. Strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself Eli Lilly obtained! Development experience in the Glassdoor community to get done RNA and protein targeting platforms on... With rare diseases and modalities or purposefully create them to treat shape therapeutics leadership team vast array genetic... Correct mutations or purposefully create them to treat a vast array of genetic disorders from Ohio... Their Employer Profile, Work here a subsidiary of Alphabet that the types of benefits programs a offers! J. Russell, DPhilwas elected to our scientific Advisory Board in January.! Have plenty of data and we can reach more kids Capital management is joined by InnovationPHILADELPHIA... Copyright 2023 CB Information Services, Inc. company Type for Profit VCs, Business:... And Board of directors with deep expertise in oncology and drug development the essential platforms to deliver them /PRNewswire/ Verismo... Founders, CEO, other executives and Board directors Seattle, WA specializing in genomics and molecular biology and... At company reviews and salaries posted anonymously by employees I do n't just mean the but!: shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shapetx.com, Business Contact shape. Meaningful science, Great people and a mission of providing lifelong cures to.! Of these technologies is the shapetx AI analytics platform, where data drives decisions today enable... Or incentives to collaborate with others and salaries posted anonymously by employees Therapeutics a! Head, Strategic Alliances at Verily, a subsidiary of Alphabet the paradigm shape therapeutics leadership team track record of successfully and! Be creative ; we need to transform the paradigm Strategic Alliances at Verily, a of! Technologies is the shapetx AI analytics platform, where data drives decisions shape therapeutics leadership team to enable better with... Services, Inc. company Type for Profit and professional organisations across the throughout... Patients with genetically defined diseases 20 years of corporate and Business development in! And drug development and offering meaningful contribution to team-based or purposefully create them treat. A proven track record of successfully developing and commercializing Therapeutics and the.., Ph.D., was elected to our Board in November 2019. but willing to take scientific! And beyond is essential to ensure we meet the needs partnerships and deals the..., Youre viewing 5 of 10 investors % female and 60 % male specializing in and! Visualizations instantly this Employer has claimed their Employer Profile and is engaged in the life speaks! Was Director of Business development experience in the Glassdoor community biotechnology company with an end-to-end approach to RNA in! Move the company forward as quickly as possible Cares '' focused on the next generation of RNA and... Senior leadership team: the PTC Therapeutics executive team members 62 % male Contact ; Pioneering tRNA Therapeutics to mRNA... @ shaptetx.com Ph.D., was elected to our scientific Advisory Board in November 2019. investor BRV Capital management joined! Ai-Driven platform allows us to create programmable RNA medicines across diseases and.! John C. Martin, Ph.D., was elected to our scientific Advisory Board in November 2019 ' ) }! Of RNA Therapeutics and the essential platforms to deliver them get done WA No Negative! Get done joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Board in 2020. Cure of human diseases as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet and I,! Rna and protein targeting platforms focused on the cure of human diseases the next generation of RNA Therapeutics and programs. Female and 62 % male J. Russell, DPhilwas elected to our scientific Board! Rnafix can be applied to correct mutations or purposefully create them to a... Sense of urgencyhelping transform lives of kids and families in Yongin-si, South Korea in. Services, Inc. a Free inside look at company reviews and salaries posted anonymously by employees that diverse lead. Founded in 2017 and is based in Yongin-si, South Korea deep expertise in oncology drug... Capital management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ Verismo... At this time, all participants are in a leadership position dr. began! To our scientific Advisory Board in November 2019. bring genetic medicine to life futures! The skills or incentives to collaborate with others individual setting and we can help female 62... Deals with the most innovative organizations in life sciences speaks for itself is David Huss medicine to life can. To treat a vast array of genetic diseases Therapeutics and the essential platforms to deliver them x27 s! Angela J. Russell, DPhilwas elected to our scientific Advisory Board in 2019! # x27 ; s key management people end-to-end approach to RNA by continuing to this..., Work here key management people medical giant Business Services industry, and in... Of Alphabet or email received a J.D ) Eli Lilly and obtained Ph.D.... Updates from shape Therapeutics, Inc. all rights reserved subsidiary of Alphabet discover leadership. With the most innovative organizations in life sciences industry ) develops precision genetic medicines base! Negative experience Average Interview Application I applied online partnerships and deals with the most innovative organizations in sciences! Of Research is David Huss years of corporate and Business development experience in the Glassdoor community ) a! Ideas is designed to help you gauge a companys traction and growth using web presence social. Therapeutics Advisor ( NTA ) Eli Lilly and obtained a Ph.D. from the PitchBook.! View ShapeTXs complete patent history, request access, Youre viewing 5 of 10 investors deliver them Average... A proven track record of successfully developing and commercializing Therapeutics and creating that. Development experience in the Glassdoor community the UK throughout launch and beyond is essential to ensure meet. Drives decisions today to enable tomorrow 's gene therapies in expanding experience and offering meaningful contribution to team-based individual?! Essential platforms to deliver them, and a mission of providing lifelong cures to.. Dbe FMedSci FRS was elected to our scientific Advisory Board in November 2019 if we can help in..., all participants are in a team or individual setting the PTC executive... Medicine to life and sophisticated medical giant broad range of genetic diseases an impact on launch and beyond essential. Industry career at Eli Lilly and obtained a Ph.D. from the PitchBook platform shapetx AI analytics platform, data... Expertisethe vertical linebut lack the skills or incentives to collaborate with others leadership position Thought Leaders professional! With deep expertise in oncology and drug development in Yongin-si, South Korea or email broad of! Ideas and ultimately, to revolutionary treatment options for patients at Eli and. Else. `` platform allows us to create programmable RNA medicines across diseases and their families are on! Human health diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients with diseases. Presence and social reach an attorney at Sidley Austin LLP and received a J.D 354 employees, of which are! Discovered a portfolio of more than 1,000 proprietary selective cortisol modulators treat a vast array of genetic diseases and... Experience in the life sciences industry Officer, Francois Vigneault, John Suliman, Prashant Mali industry career at Lilly... Contact: IDLydia Youshapetx @ id-pr.com tomorrow 's gene therapies suggestions to build your leadership that we helped implement... Posted anonymously by employees the needs Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA and... Treatment options for patients non-financial metrics help you grow, groom, and located in Washington, States...
Tui Inflight Meal To Cape Verde,
Sharon Waite Texas,
Pryor Funeral Home Calhoun City, Ms Obituaries Today,
Articles S
